Prognostic value of lung ultrasound in patients hospitalized for heart disease irrespective of symptoms and ejection fraction.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
08 2021
Historique:
revised: 14 11 2020
received: 11 07 2020
accepted: 02 01 2021
pubmed: 2 5 2021
medline: 29 10 2021
entrez: 1 5 2021
Statut: ppublish

Résumé

Lung ultrasound B-lines are the sonographic sign of pulmonary congestion and can be used in the differential diagnosis of dyspnoea to rule in or rule out acute heart failure (AHF). Our aim was to assess the prognostic value of B-lines, integrated with echocardiography, in patients admitted to a cardiology department, independently of the initial clinical presentation, thus in patients with and without AHF, and in AHF with reduced and preserved ejection fraction (HFrEF and HFpEF). We enrolled consecutive patients admitted for various cardiac conditions. Patients were classified into three groups: (i) acute HFrEF; (ii) acute HFpEF; and (iii) non-AHF. All patients underwent an echocardiogram coupled with lung ultrasound at admission, according to standardized protocols. We followed up 1021 consecutive inpatients (69 ± 12 years) for a median of 14.4 months (interquartile range 4.6-24.3) for death and rehospitalization for AHF. During the follow-up, 126 events occurred. Admission B-lines > 30, ejection fraction < 50%, tricuspid regurgitation velocity > 2.8 m/s, and tricuspid annular plane systolic excursion < 17 mm were independent predictors at multivariable analysis. B-lines > 30 had a strong predictive value in HFpEF and non-AHF, but not in HFrEF. Ultrasound B-lines can detect subclinical pulmonary interstitial oedema in patients thought to be free of congestion and provide useful information not only for the diagnosis but also for the prognosis in different cardiac conditions. Their added prognostic value among standard echocardiographic parameters is more robust in patients with HFpEF compared with HFrEF.

Identifiants

pubmed: 33932105
doi: 10.1002/ehf2.13206
pmc: PMC8318481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2660-2669

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Eur J Heart Fail. 2010 May;12(5):423-33
pubmed: 20354029
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Chest. 2020 Jan;157(1):99-110
pubmed: 31381880
JACC Heart Fail. 2017 Nov;5(11):763-771
pubmed: 29032140
Eur Heart J. 2016 Apr 14;37(15):1244-51
pubmed: 26819225
Eur J Heart Fail. 2020 Mar;22(3):458-468
pubmed: 31950651
Nephrol Dial Transplant. 2016 Dec;31(12):1982-1988
pubmed: 27672089
Eur J Heart Fail. 2019 Jul;21(7):904-916
pubmed: 30666769
ESC Heart Fail. 2021 Aug;8(4):2660-2669
pubmed: 33932105
Cardiovasc Ultrasound. 2015 Sep 04;13:40
pubmed: 26337295
ESC Heart Fail. 2020 Oct;7(5):2621-2628
pubmed: 32633473
Eur J Heart Fail. 2019 Dec;21(12):1605-1613
pubmed: 31667987
Eur J Heart Fail. 2019 Jun;21(6):754-766
pubmed: 30690825
Circulation. 2008 Sep 30;118(14):1433-41
pubmed: 18794390
JACC Cardiovasc Imaging. 2013 Nov;6(11):1141-51
pubmed: 24094830
JACC Heart Fail. 2018 Apr;6(4):273-285
pubmed: 29226815
Am J Cardiol. 2019 May 1;123(9):1470-1477
pubmed: 30777323
Circulation. 2005 Aug 9;112(6):841-8
pubmed: 16061743
Clin Res Cardiol. 2018 Jul;107(7):586-596
pubmed: 29532155
Eur J Heart Fail. 2019 Jul;21(7):844-851
pubmed: 31218825
Eur J Echocardiogr. 2007 Dec;8(6):474-9
pubmed: 17116422
Cardiovasc Ultrasound. 2006 Aug 31;4:34
pubmed: 16945139
Eur J Heart Fail. 2008 Jan;10(1):70-7
pubmed: 18077210
Intensive Care Med. 2012 Apr;38(4):577-91
pubmed: 22392031
Int J Cardiol. 2016 Sep 1;218:104-108
pubmed: 27232920
Eur J Heart Fail. 2015 Jun;17(6):544-58
pubmed: 25999021
Sci Rep. 2016 Dec 20;6:39426
pubmed: 27995971
Heart Fail Clin. 2019 Apr;15(2):297-303
pubmed: 30832819
J Card Fail. 2007 Dec;13(10):830-5
pubmed: 18068616
JACC Heart Fail. 2019 Oct;7(10):849-858
pubmed: 31582107
Eval Health Prof. 2003 Sep;26(3):239-57
pubmed: 12971199
Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):828-836
pubmed: 30753369
Chest. 2005 May;127(5):1690-5
pubmed: 15888847
Heart Fail Rev. 2020 Jan;25(1):119-131
pubmed: 31628648
Cardiovasc Ultrasound. 2011 Feb 27;9:6
pubmed: 21352576

Auteurs

Luna Gargani (L)

Institute of Clinical Physiology - C.N.R., Pisa, Italy.

Nicola Riccardo Pugliese (NR)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Francesca Frassi (F)

Emergency Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Paolo Frumento (P)

Department of Political Sciences, University of Pisa, Pisa, Italy.

Elisa Poggianti (E)

Fondazione Toscana G. Monasterio, Pisa, Italy.

Matteo Mazzola (M)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Nicolò De Biase (N)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Patrizia Landi (P)

Institute of Clinical Physiology - C.N.R., Pisa, Italy.

Stefano Masi (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Stefano Taddei (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Peter S Pang (PS)

Department of Emergency Medicine, Indiana University, Indianapolis, IN, USA.

Rosa Sicari (R)

Institute of Clinical Physiology - C.N.R., Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH